Document Detail

Thermogenic Supplement Use Does Not Alter Characteristics of Sudden Death in the Young.
MedLine Citation:
PMID:  22946739     Owner:  NLM     Status:  Publisher    
Background: To evaluate supplement use, most notably ephedra, which has been temporally associated with sudden death. Animal models suggest increased myocardial irritability may predispose to primary arrhythmic death. Methods: Clinical, pathological, and investigative records from the Office of the Armed Forces Medical Examiner's Cardiovascular Death Registry were reviewed. Forty-eight cases of those with known supplement use were compared to 144 age-, gender-, and socioeconomic-matched controls in a 1:3 case:control manner. Results: Of the 48 sudden deaths temporally associated with supplement use, the mean age was 34.2 ± 10.0 years and predominantly male (n = 44, 91.7%). The underlying cause of death was fatal atherosclerotic coronary disease in 18 (37.5%), sudden unexplained death in 16 (33.3%), and hypertrophic cardiomyopathy in six (12.5%). Compared with controls, there were no statistically significant differences in adjudicated cause of death. On autopsy, there were no differences in cardiac mass, ventricular wall thickness, or presence of atherosclerosis in those known to be taking identified supplements compared to a control population. In the subject ≥35 years, and known to be taking supplements, there was a significant increase in causality of death as due to sudden unexplained death (relative risk = 5.1 [95% confidence interval, 1.4-18.7]). Conclusions: Active surveillance of mortality in an autopsy-derived series of young adults finds atherosclerotic coronary disease and idiopathic sudden death are common etiologies of death when taking supplements, but no cardiac structural or histologic mechanism to suggest different pathologic process than a matched control population. (PACE 2012;00:1-6).
David A Appel; Jennifer A McNear; Eric A Shry; Philip J Gentlesk; Stephen S Reich; Robert E Eckart;
Related Documents :
6887169 - Myocardial involvement in polymyositis.
10475079 - Use of biochemical markers in acute coronary syndromes. ifcc scientific division, commi...
10451239 - Clinical application of markers of cardiac injury: basic concepts and new considerations.
21364469 - Myocardial iron loading in patients with thalassemia major in turkey and the potential ...
1860469 - Release of creatine kinase-mb and cardiac specific troponin-i following percutaneous tr...
16269219 - The relevance of the detection of troponins to the forensic diagnosis of cardiac contus...
18582629 - Acute heart failure syndromes and coronary perfusion.
1990749 - Factors associated with recurrent myocardial infarction within one year after acute myo...
152169 - Prevalence and characteristics of disporportionate ventricular septal thickening in inf...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-4
Journal Detail:
Title:  Pacing and clinical electrophysiology : PACE     Volume:  -     ISSN:  1540-8159     ISO Abbreviation:  Pacing Clin Electrophysiol     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7803944     Medline TA:  Pacing Clin Electrophysiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
©2012, The Authors. Journal compilation ©2012 Wiley Periodicals, Inc.
Wright Patterson Air Force Base, Dayton, Ohio San Antonio Military Medical Center, San Antonio, Texas Landstuhl Regional Medical Center, Landstuhl, Germany Cardiology Consultants, Virginia Beach, Virginia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical management of insomnia with brief behavioral treatment (BBTI).
Next Document:  Regioselective Catalytic Hydroboration of Propargylic Species Using Cu(I)-NHC Complexes.